Rectal prolapse screening: Difference between revisions

	Rectal prolapse Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Rectal Prolapse from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Abdominal X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Rectal prolapse screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Rectal prolapse screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Rectal prolapse screening
CDC on Rectal prolapse screening
Rectal prolapse screening in the news
Blogs on Rectal prolapse screening
Directions to Hospitals Treating Rectal prolapse
Risk calculators and risk factors for Rectal prolapse screening

Revision as of 16:08, 31 January 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]

There is insufficient evidence to recommend routine screening for rectal prolapse.

@@ Line 5: / Line 5: @@
 ==Overview==
-There is insufficient evidence to recommend routine screening for [disease/malignancy].
-OR
-According to the [guideline name], screening for [disease name] is not recommended.
-OR
-According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
 ==Screening==
-*There is insufficient evidence to recommend routine screening for [disease/malignancy].
+There is insufficient evidence to recommend routine screening for rectal prolapse.
-OR
-*According to the [guideline name], screening for [disease name] is not recommended.
-OR
-*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
-**[Condition 1]
-**[Condition 2]
-**[Condition 3]
 ==References==